Application Notes

Proximity Inducers in Drug Discovery - A Perspective on Cooperativity

Issue link: https://resources.nanotempertech.com/i/1533610

Contents of this Issue

Navigation

Page 4 of 8

5 A P P L I C A T I O N N O T E Figure 2. Dianthus with Spectral Shift technology. DIANTHUS: ADVANCING COOPERATIVITY SCREENING To address the challenges in proximity inducer screening, Dianthus integrates cutting-edge Spectral Shi technology, which was specifically designed to overcome the limitations of traditional binding assays. According to Hans-Jörg, the selection of this method for some difficult projects, came out of a need to monitor weak target binding. "We tried the usual methods like SPR and FRET, but they failed to measure K d s greater than 50 μM.", Hans-Jörg shared. It was this persistent issue that led him and his team to turn to Spectral Shi technology. The key advantage of this method, Hans-Jörg notes, is that it is a pure target engagement technique. Unlike other affinity assays that require tagging both proteins — such as FRET — Spectral Shi technology monitors only the target protein. "It's a direct measurement of changes on the target itself, without the need for labeling both proteins, making the assay easier and more precise," Hans- Jörg explains. This results in a more accurate and sensitive way to characterize proximity inducers, particularly when assessing the cooperativity of these ternary complexes. U S E R C A S E S T U D Y

Articles in this issue

view archives of Application Notes - Proximity Inducers in Drug Discovery - A Perspective on Cooperativity